Blood clots in veins that drain blood from the brain can lead to alarming strokelike results. The symptoms can be severe headaches, abdominal pain, leg pain and shortness of breath.
That’s why it made sense for federal, state and local health officials to hit the pause button Tuesday and again on Wednesday on continued distribution of the Johnson & Johnson COVID-19 vaccine. Six known cases of a rare clotting disorder called cerebral venous sinus thrombosis in women between the ages of 18 and 48 might be linked to the vaccine, health officials said. More information is needed.